Navigation Links
Obamacare Ruling, Other Pivotal News Rocks Biotech Sector in June
Date:6/28/2012

ATLANTA, June 28, 2012 /PRNewswire-USNewswire/ -- From today's Supreme Court ruling that upholds the Affordable Care Act (ACA) to the FDA's approval of the first new obesity drug in 13 years, June has been a hot month for major news impacting the U.S. biotechnology sector.

(Logo: http://photos.prnewswire.com/prnh/20120628/DC32901LOGO)

Biopharmaceutical drugmakers have held their collective breath wondering what would happen with health care reform and many hesitated to commit resources to implement certain provisions, such as those related to the Physician Payments Sunshine Act, which requires them to report payments made to physicians and teaching hospitals. With this ruling, it's now clear they need to act. The ACA also protects a 12-year marketing exclusivity provision for biologics and upholds a regulatory pathway for biosimilars, which is positive news for biopharmas.

"Bottom line, despite the myriad complexities which biotechs must now weed through, the ACA translates into important business opportunities for biopharmas, not the least of which is a burgeoning biosimilars sub-industry," said Lynn Yoffee, executive editor of BioWorld Today. "Despite over-hanging world economic conditions, biotech is one U.S. business sector that is working. The sector grew by 6.4 percent between 2001-2010 compared to a 2.9 percent decline in overall U.S. private-sector jobs. Twenty-two new biotech drugs have been approved already in 2012, the latest including promising new drugs for breast cancer and obesity. President Obama is poised to sign critical legislation which creates new user fees for generics and biosimilars. And capping off June, the Supreme Court upheld the ACA, yielding both positive and negative ripples."

BioWorld has kept industry insiders abreast of these key stories as they happen, sometimes within minutes. "And we go beyond the breaking news; we provide key
'/>"/>

SOURCE BioWorld
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
3. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
4. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
5. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
6. Middle East and Africa Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
7. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
8. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
9. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
10. Clove Oil, a Natural Pesticide Used on Apples and Other Fruit, May Cause Dermatitis
11. Reduction of Chemotherapy and PET-Guided Radiotherapy in Advanced-Stage Hodgkin Lymphoma: the GHSG HD15 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and Markets ... Drug Pipeline Insight 2014" report to their offering. ... US is one of the largest segments of pharmaceuticals industry. ... rate, while the available therapies were unable to meet the ... the market for CNS disorder, especially over the past two ...
(Date:8/29/2014)... Vittamed Corporation , a neurodiagnostics medical device company based in ... (Teo) Forcht Dagi , MD, DmedSc, MPH, MBA, FACS, FRCSEd ... " Teo Forcht Dagi is an experienced leader ... capital," said Remis Bistras , President and CEO of ... and entrepreneurial expertise to our Board." Dr. Dagi ...
(Date:8/29/2014)... 2014 Research and Markets has ... Drugs Market 2014-2018" report to their offering. ... condition that results in demyelination, axonal transection, and neurodegeneration. ... response by the immune system, which targets neurons within ... debilitating disease in which the damage of the myelin ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
(Date:9/1/2014)... (PRWEB) September 01, 2014 The Outlier ... with extended exclusive interview content from one of the ... Ingredients of Outliers: Women Game Changers . The title ... Outliers: Woman Game Changer Jenny McClendon . McClendon is ... and was formerly the star of WeTV show, Raising ...
(Date:9/1/2014)... Nevada (PRWEB) September 01, 2014 Beginning ... to over 3,000 medical professionals and 10,000 consumers for ... is a 5-day gathering of the nation’s top medical ... associated diseases or conditions. The week-long event contains more ... evidence-based scientific instruction available in the pain management field. ...
(Date:8/31/2014)... Washington, D.C.USA (PRWEB) August 31, 2014 ... the global community utilizing social media marketing tools ... and interactive programs. MMU will utilize all tools ... become learning partner for our multiple learning channels. ... new mobile app, and an authoring tool that ...
(Date:8/31/2014)... GoDaddy, IX Web Hosting and Bluehost ... Private Server) hosting, which is the method of ... each of which has the appearance and capabilities ... has recently compared many professional web hosting suppliers ... best VPS hosting suppliers in the global market. ...
(Date:8/31/2014)... In order to celebrate the coming of autumn, ... designs and launched a big promotion. Now, all the global ... the company’s new cars are made with great materials. FODAY ... customers. As a matter of fact, it is providing big ... are in need of cheap cars can visit its website ...
Breaking Medicine News(10 mins):Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3Health News:GoDaddy, IX Web Hosting and Bluehost Are Awarded As Hosting Experts by Top10BestSEOHosting.com 2
... Doheny HealthDay Reporter , WEDNESDAY, March 28 (HealthDay ... a woman,s risk of breast cancer by about 5 percent, ... drinking -- three or more drinks a day -- can ... Germany, France and Italy. "Alcohol consumption is ...
... Vanderbilt-Ingram Cancer Center researchers have identified a new population of ... of colorectal cancer. , This new stem cell population, reported ... be relatively quiescent (inactive) in contrast to the recent ... is marked by a protein, Lrig1, that may act as ...
... new UK alcohol strategy includes a plan to ensure that ... Government,s Alcohol Strategy, 23 March 2012, downloadable from http://www.homeoffice.gov.uk/publications/ ... much people drink. The big question is, what should GPs ... online by the scientific journal Addiction analysed the ...
... (HealthDay News) -- A drink or two per day may help ... a heart attack, a new study suggests. The research, which ... included more than 1,800 American men who survived a first heart ... 20 years. During that time, 468 of the men died. ...
... -- The common cold appears to increase the number ... more sensitive, which triggers coughing, wheezing and breathlessness, a ... vulnerable to this virus-induced coughing, said the researchers from ... as transient receptor potential (TRP) receptors. "TRP ...
... -- Researchers have identified genetic causes in nearly 1 in ... dilated cardiomyopathy. Carolyn Jones, MD, PhD, of Loyola University ... Journal of Cardiac Failure . First author is Neal ... genetic testing on 264 patients with dilated cardiomyopathy and found ...
Cached Medicine News:Health News:Even a Little Drinking May Raise Breast Cancer Risk: Study 2Health News:Even a Little Drinking May Raise Breast Cancer Risk: Study 3Health News:Newly identified stem cells may hold clues to colon cancer 2Health News:Moderate Drinking Might Help Men Live Longer After Heart Attack 2Health News:Research Shows How Colds Lead to Coughing, Wheezing 2Health News:Genetic causes found in nearly 1 in 5 patients with dilated cardiomyopathy heart failure 2
Contains 50 mg/ml gentamicin sulfate in distilled water....
Gentamicin is an aminoglycosidic antibiotic that inhibits bacterial growth by inhibiting protein synthesis. Gentamicin is used for prevention and elimination of bacterial contaminants in cell culture...
LB Agar plates with 10mM Magnesium Sulfate....
LB Agar plates with 0.1mM EDTA....
Medicine Products: